Clinical Manufacturing
- cGMP manufacturing through phase I, II & III
- Direct API fill into capsules (using Xcelodose 600 and 600S)
- Dosage form preparation and blinding
- Open and blinded clinical packaging and labeling
- Semi-automated and fully automated overencapsulation
- Wet and dry granulation
- Tableting
- Coating: beads and tablets
- Encapsulation for powders, granules, tablets and mixed combinations
- Schedule II - V control drug manufacturing
Formulation Development
- Complex Formulations
- Improving Solubility
- Brevi - Batch®
Clinical Manufacturing
- cGMP Manufacturing
- Phase I - III
- Direct API Fill into Capsules
Commercial Manufacturing
- FDA Inspected
- Solid Oral Dosage Forms
- DEA Controlled Substances
